Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: dwight martin who wrote (10105)	5/19/1999 4:37:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Read about Manny on Ranging Bull Boards. His bio is there. He works in the biotech area and writes on biotech area for RB. Also answers questions from posters. I asked him about XOMA's non disclosure and this is his reply. Opal I did not post url because I think you must register. It is free. Raging TZAVL Links By: MannyTZ Reply To: 247 by georgew Wednesday, 19 May 1999 at 11:25 AM EDT Post # of 248 georgew: I agree with you wholehartedly about XOMA disclosing the mortality data. I hear Micheal Murphy is touting that XOMA can be a $45 stock in the near future!! I have to disclose that I am a XOMA shareholder and would LOVE for it to go to $45, but $12-13 would make me happy as well! Your concept on results of trials being released to shareholders before being presented at an appropriate scientific forum is an interesting one, and I agree with you if the scientific forum is a long way ahead. But you have to keep in mind that many of the smaller biotech stocks do not have analysts covering their progress and need a large forum of this type to create buzz. So it is imperative for them to wait before they post their data. Thanks for the questions and please update the board on anything you hear about XOMA.